PER2 V903I

PER2 V903I — The Night Owl Clock Variant

The PER2 gene encodes Period Circadian Regulator 2 | One of three Period
proteins forming the core negative feedback arm of the mammalian circadian
clock, suppressing CLOCK:BMAL1-driven transcription,
one of the master gears of your internal 24-hour clock. PER2 protein
accumulates during the day, enters the nucleus, and shuts down the
CLOCK:BMAL1 transcription complex — resetting the cycle. The rs35333999
variant changes a valine to isoleucine at position 903, in a region that
overlaps a predicted interaction interface with PPARG | The nuclear receptor
involved in adipogenesis and metabolic regulation,
suggesting a link between circadian timing and metabolism.

This variant is notable because it is the strongest association signal that
peaks directly within a core circadian clock gene in
genome-wide association studies of chronotype | Jones et al. identified
rs35333999 in 100,420 UK Biobank participants at P=10^-8, later replicated
at P=9.7x10^-14 in 335,789 individuals.
Most chronotype GWAS signals map to regulatory or intergenic regions —
PER2 V903I is a coding change in the heart of the clock machinery.

The Mechanism

The V903I substitution alters a conserved valine in exon 19 of the
canonical PER2 transcript. Computational analysis predicts this change
as probably damaging | PolyPhen-2 score of 0.963, indicating high
likelihood of functional impact.
The valine-to-isoleucine change is conservative (both are hydrophobic
branched-chain amino acids), but the position is conserved across
mammalian species | suggesting functional constraint at this
site, and the V903
residue sits at a predicted protein-protein interaction interface.

The functional consequence is a measurable lengthening of intrinsic
circadian period — the fundamental oscillation speed of the molecular
clock. A longer period means the clock "runs slow," requiring more
environmental resetting (via light) each day to stay synchronized with
the 24-hour world. When the clock runs slow, the natural tendency is to
drift later — later sleep onset, later wake time, and a preference for
evening activity.

The Evidence

The key study establishing both population-level chronotype association
and mechanistic causation was
Chang et al. 2019 | Chang A-M et al. Chronotype Genetic Variant in PER2
is Associated with Intrinsic Circadian Period in Humans. Sci Rep,
2019. This study combined
large-scale GWAS data with precisely controlled laboratory measurements:

In the UK Biobank cohort of 335,789 individuals | unrelated participants
of European ancestry, the T
allele reached genome-wide significance for self-reported eveningness
(P = 9.7 x 10^-14, beta = 0.058). This replicated and strengthened the
earlier signal from
Jones et al. 2016 | in 100,420 UK Biobank participants at P = 10^-8.

The same study then measured intrinsic circadian period in a subset of
participants under highly controlled
forced desynchrony protocols | Laboratory protocols where participants
live on non-24-hour schedules to unmask the endogenous circadian period
from environmental time cues.
T allele carriers showed a 12-minute longer circadian period by both
core body temperature | 24.34 +/- 0.17 h vs 24.14 +/- 0.20 h, P = 0.030
and plasma melatonin | 24.34 +/- 0.18 h vs 24.15 +/- 0.19 h,
P = 0.039 measurements. The
variant accounted for approximately 7% of inter-individual variance in
circadian period — a substantial effect for a single SNP.

The expanded chronotype GWAS of 697,828 individuals | Jones et al.
2019 confirmed PER2 as one
of 351 loci associated with chronotype, and identified enrichment in
circadian rhythm pathways, retinal light-sensing, and insulin signaling.

Practical Implications

A 12-minute longer circadian period may sound small, but it compounds
daily. Without sufficient morning light exposure to reset the clock each
day, carriers drift progressively later. This has real consequences for
metabolic health: evening chronotypes consistently show higher rates of
type 2 diabetes, obesity, and cardiovascular disease in epidemiological
studies, driven by late eating, disrupted meal-activity synchronization,
and social jet lag.

The overlap of the V903I position with a predicted PPARG interaction
interface is intriguing. PPARG is a key regulator of adipocyte
differentiation and insulin sensitivity. If V903I alters PER2-PPARG
interaction, it could directly link circadian period length to metabolic
outcomes — though this protein-protein interaction has not yet been
confirmed experimentally.

Interactions

PER2 V903I interacts functionally with other circadian clock gene
variants. The CLOCK rs1801260 G allele increases CLOCK protein levels,
potentially amplifying PER2 expression; combined with a PER2 variant that
slows the clock, the result could be additive circadian delay. Similarly,
PER3 rs228697 (Pro864Ala) and PER3 rs10462020 (Val647Gly) affect
the Period protein arm of the same feedback loop. Carriers of multiple
evening-shifting alleles across PER2, PER3, and CLOCK likely experience
more pronounced circadian delay than any single variant predicts.

Compound implication for PER2 rs35333999 + CLOCK rs1801260: Individuals
carrying both the PER2 T allele (CT or TT) and the CLOCK G allele (AG or
GG) may experience compounded evening-shifting effects — both increased
CLOCK protein driving the positive limb and a slowed PER2 negative
feedback loop. These carriers would benefit most from aggressive morning
light exposure and strict meal timing.